New program targeting expensive new drugs

CVS Caremark announced a new program that will allow its clients to exclude coverage of drugs with extremely high launch prices in an aim at pressuring manufacturers to lower drug costs. CVS said the new program will use specific methods of comparing the cost and effectiveness of certain expensive drugs. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.